UCB establishes innovative collaboration with Harvard University
28 February 2011 | By UCB
UCB announced today that it has concluded an innovative research collaboration agreement with Harvard University...
List view / Grid view
News
David Redfern appointed as new Chairman of ViiV Healthcare
25 February 2011 | By GlaxoSmithKline
GSK, ViiV Healthcare, & Pfizer announced the appointment of David Redfern as the new Chairman of the Board for ViiV Healthcare...
Sigma® Life Science launches pre-designed CompoZr® Knockout ZFN for entire human genome
24 February 2011 | By kdm communications limited
The new offer, attractively priced to fit within the budget of a typical laboratory...
Nampak Healthcare proposes major investment in Portsmouth
24 February 2011 | By Crosland Communications Ltd
Nampak Healthcare announced plans to invest in a new facility in Segensworth...
GE Healthcare appoints Kieran Murphy as Life Sciences CEO, successor to Peter Ehrenheim
24 February 2011 | By GE Healthcare
Kieran Murphy will be promoted to succeed current Life Sciences President and CEO...
Court of Appeals overturns $1.8bn patent verdict for Centocor Ortho Biotech Inc.
23 February 2011 | By Johnson & Johnson
Centocor received a decision from the Court of Appeals overturning a 2009 federal court jury verdict that awarded the company $1.8 billion...
Brecon appoints Director of QA and Regulatory Affairs
23 February 2011 | By AD Communications
Brecon Pharmaceuticals, has appointed Qualified Person Kay O'Hagan as director of quality assurance & regulatory affairs...
Flexicon FF30 – new and improved tabletop filling and capping machine
23 February 2011 | By Content Communications
Flexicon Liquid Filling, is introducing a new and improved version of its established FF30 tabletop filling and capping machine...
Onglyza™ US label update provides further evidence regarding use in renally impaired adults with type 2 diabetes
23 February 2011 | By AstraZeneca
The FDA has approved the inclusion of data from two clinical studies...
New treatment choice for advanced kidney cancer patients as Votrient®▼ made available on the NHS
23 February 2011 | By Packer Forbes Communications
Patients with advanced renal cell carcinoma, can access Votrient® on the NHS...
Gilead Sciences to acquire Calistoga Pharmaceuticals for $375 million
22 February 2011 | By Gilead Sciences
Gilead Sciences, Inc. & Calistoga Pharmaceuticals, Inc., announced the signing of a definitive agreement pursuant to which Gilead will acquire Calistoga for $375 million...
ERT announces the appointment of Eric Schwartz as Chief Legal Officer
22 February 2011 | By The Scott Partnership
ERT announced the appointment of Eric Ian Schwartz as Executive Vice President and Chief Legal Officer effective February 22...
HUBER offer ATEX rated solutions for the Unistat® range of high precision temperature control systems
22 February 2011 | By Peter Huber Kältemaschinenbau GmbH
ATEX solutions for zones 1 & 2, offer two options to address application complexities...
Sigma® Life Science launches oncology disease model cell lines
21 February 2011 | By kdm communications limited
New cell lines offer cellular models of cancer that are expected to enhance development of drugs for personalised medicine...
Anirvan Ghosh named Head of Discovery for Roche’s CNS
21 February 2011 | By Roche
Role will focus on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression & neurodevelopment...
